Adenosine antagonists as potential therapeutic agents
- 1 February 1988
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 29 (2), 433-441
- https://doi.org/10.1016/0091-3057(88)90182-7
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Adenosine and asthmaTrends in Pharmacological Sciences, 1986
- Chronic caffeine treatment reduces caffeine but not adenosine effects on cortical acetylcholine releaseBritish Journal of Pharmacology, 1986
- Effects of (−)-N6-(R-phenylisopropyl)-adenosine (PIA) and caffeine on nociception and morphine-induced analgesia, tolerance and dependence in miceEuropean Journal of Pharmacology, 1985
- Sensitivity of inbred mice to methylxanthines is not determined by plasma xanthine concentrationNeuroscience Letters, 1985
- PACPX ‐ a substituted xanthine ‐ antagonizes both the A1 and A2 subclasses of the P1‐purinoceptor: antagonism of the A2 subclass is competitive but antagonism of the A1 subclass is notBritish Journal of Pharmacology, 1985
- Increased Anxiogenic Effects of Caffeine in Panic DisordersArchives of General Psychiatry, 1985
- Neurohumoral Control of Blood VesselsJournal of Cardiovascular Pharmacology, 1985
- CGS 9896: A nonbenzodiazepine, nonsedating potential anxiolyticDrug Development Research, 1984
- Adenosine: a physiological modulator of superoxide anion generation by human neutrophils.The Journal of Experimental Medicine, 1983
- THE CHRONIC ORAL TOXICITY OF CAFFEINECanadian Journal of Physiology and Pharmacology, 1965